Director, Regional Market Access, Urology, EMEA

Confirmed live in the last 24 hours

Veracyte

Germany

Remote

Posted March 6, 2026

Job Description

At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help patients make life-changing decisions.

Our Values:

We Seek A Better Way: We innovate boldly, learn from our setbacks, and are resilient in our pursuit to transform cancer care
We Make It Happen: We act with urgency, commit to quality, and bring fun to our hard work
We Are Stronger Together: We collaborate openly, seek to understand, and celebrate our wins
We Care Deeply: We embrace our differences, do the right thing, and encourage each other

The Position:

As the Director, Regional Market Access, Urology, EMEA, you will be the strategic driver for enabling patient access to our urology portfolio across key EMEA markets. In this senior individual contributor role, you will lead regional market access strategy, shape payer value narratives, and partner closely with cross functional teams to secure and maintain reimbursement pathways. You’ll influence regional decision making without direct people management—acting as a trusted thought leader who brings clarity, rigor, and creativity to complex access environments.

This role is ideal for someone who thrives in ambiguous, multi‑market settings, enjoys solving sophisticated market access challenges, and embodies our Veracyte values—collaborative, resilient, innovative, and deeply committed to improving patient outcomes.

Responsibilities

Develop and execute the regional market access strategy for the Urology portfolio across priority EMEA markets.
Serve as the regional subject matter expert in payer evidence requirements, reimbursement processes, pricing frameworks, and HTA pathways.
Lead development of value propositions, payer communication tools, and regionally optimized access materials in collaboration with Medical Affairs, HEOR, Clinical, and Marketing.
Engage with regional decision‑makers—including HTA assessors, payers, clinical KOLs, and advocacy groups—to shape understanding of clinical utility and economic value.
Provide strategic guidance and partnership to country teams to support market‑specific submissions, development of health economic models, pricing strategies, and reimbursement negotiations.
Collaborate closely with Medical Affairs to define regional evidence generation needs and inform clinical/real‑world data priorities.
Interpret evolving policy, regulatory, and reimbursement trends across EMEA, translating them into actionable insights for cross‑functional partners.
Lead cross‑functional access planning during launches, expansions, and lifecycle milestones.
Drive and support Market Access projects as part of the Breast Cancer portfolio upon request.
Represent Market Access leadership in regional and global strategic forums, influencing direction across multiple teams (consistent with Director‑level expectations for broad organizational impact).
Embody and model the Veracyte Way—engaging stakeholders early, debating thoughtfully, innovating with purpose, acting with integrity, and driving progress with urgency.

Who You Are:

Required Qualifications

10+ years’ experience in market access, reimbursement, payer strategy, or health economics within diagnostics, medical devices, or specialty therapeutics.
Deep understanding of HTA processes and payer decision frameworks across major EMEA markets and successful experiences from European HTA processes e.g. IQWIG/GBA, HAS or NICE.
Proven success developing regional market access strategies and value narratives for scientifically comple

gorustaidataproductmarketingsales